LILRB1 Blockade Enhances Bispecific T Cell Engager Antibody–Induced Tumor Cell Killing by Effector CD8+ T Cells

AeRyon Kim(Amgen (United States)), Xin Yu(Jiangnan University), Andrew K. Sewell(Cardiff University), Ian Driver(Amgen (United States)), Aleksandra Olow(Amgen (United States)), Jackson G. Egen, Chia-Jung Han, Zemin Zhang(Peking University), Wenjun Ouyang
The Journal of Immunology
June 28, 2019
10.4049/jimmunol.1801472
Cited by 45

Related Papers

The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer
|Cell|2020|1.6k
Lineage tracking reveals dynamic relationships of T cells in colorectal cancer
|Nature|2018|1.5k
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
|Nature Immunology|2008|1.5k
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8 + T Cell Effector Function
|Cancer Cell|2014|1.1k